146 related articles for article (PubMed ID: 460294)
1. The cytotoxic, mutagenic and clastogenic effects of chromium-containing compounds on mammalian cells in culture.
Newbold RF; Amos J; Connell JR
Mutat Res; 1979 May; 67(1):55-63. PubMed ID: 460294
[TBL] [Abstract][Full Text] [Related]
2. Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis.
Wise JP; Stearns DM; Wetterhahn KE; Patierno SR
Carcinogenesis; 1994 Oct; 15(10):2249-54. PubMed ID: 7955062
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake.
Wise JP; Orenstein JM; Patierno SR
Carcinogenesis; 1993 Mar; 14(3):429-34. PubMed ID: 8453719
[TBL] [Abstract][Full Text] [Related]
4. Effect of lead chromate on chromosome aberration, sister-chromatid exchange and DNA damage in mammalian cells in vitro.
Douglas GR; Bell RD; Grant CE; Wytsma JM; Bora KC
Mutat Res; 1980 Feb; 77(2):157-63. PubMed ID: 7374664
[TBL] [Abstract][Full Text] [Related]
5. Lead chromate-induced chromosome damage requires extracellular dissolution to liberate chromium ions but does not require particle internalization or intracellular dissolution.
Xie H; Holmes AL; Wise SS; Gordon N; Wise JP
Chem Res Toxicol; 2004 Oct; 17(10):1362-7. PubMed ID: 15487897
[TBL] [Abstract][Full Text] [Related]
6. Particulate and soluble hexavalent chromium are cytotoxic and genotoxic to human lung epithelial cells.
Wise SS; Holmes AL; Wise JP
Mutat Res; 2006 Nov; 610(1-2):2-7. PubMed ID: 16872863
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and clastogenic effects of soluble and insoluble compounds containing hexavalent and trivalent chromium.
Levis AG; Majone F
Br J Cancer; 1981 Aug; 44(2):219-35. PubMed ID: 7272188
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic, mutagenic and clastogenic effects of industrial chromium compounds.
Venier P; Montaldi A; Majone F; Bianchi V; Levis AG
Carcinogenesis; 1982; 3(11):1331-8. PubMed ID: 6758977
[TBL] [Abstract][Full Text] [Related]
9. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts.
Biedermann KA; Landolph JR
Cancer Res; 1990 Dec; 50(24):7835-42. PubMed ID: 2253225
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenicity and mutagenicity of chromium.
Léonard A; Lauwerys RR
Mutat Res; 1980 Nov; 76(3):227-39. PubMed ID: 7010127
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic and neoplastic transforming effects of industrial hexavalent chromium pigments in Syrian hamster embryo cells.
Elias Z; Poirot O; Pezerat H; Suquet H; Schneider O; Danière MC; Terzetti F; Baruthio F; Fournier M; Cavelier C
Carcinogenesis; 1989 Nov; 10(11):2043-52. PubMed ID: 2680145
[TBL] [Abstract][Full Text] [Related]
12. The clastogenic effects of chronic exposure to particulate and soluble Cr(VI) in human lung cells.
Holmes AL; Wise SS; Sandwick SJ; Wise JP
Mutat Res; 2006 Nov; 610(1-2):8-13. PubMed ID: 16870495
[TBL] [Abstract][Full Text] [Related]
13. Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells.
Wise SS; Holmes AL; Ketterer ME; Hartsock WJ; Fomchenko E; Katsifis S; Thompson WD; Wise JP
Mutat Res; 2004 May; 560(1):79-89. PubMed ID: 15099827
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and genotoxicity of hexavalent chromium in human and North Atlantic right whale (Eubalaena glacialis) lung cells.
Li Chen T; Wise SS; Holmes A; Shaffiey F; Wise JP; Thompson WD; Kraus S; Wise JP
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Nov; 150(4):487-94. PubMed ID: 19632355
[TBL] [Abstract][Full Text] [Related]
15. The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells.
Wise JP; Wise SS; Little JE
Mutat Res; 2002 May; 517(1-2):221-9. PubMed ID: 12034323
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of chromosomal aberration and mutagenicity of the trivalent and hexavalent chromium.
Nakamuro K; Yoshikawa K; Sayato Y; Kurata H
Mutat Res; 1978 Nov; 58(2-3):175-81. PubMed ID: 745615
[TBL] [Abstract][Full Text] [Related]
17. [Mutagenic activity of chromium compounds].
Pashin IuV; Kozachenko VI
Gig Sanit; 1981 May; (5):46-9. PubMed ID: 7016679
[No Abstract] [Full Text] [Related]
18. Effects of nitrilotriacetic acid on the induction of gene mutations and sister-chromatid exchanges by insoluble chromium compounds.
Venier P; Montaldi A; Gava C; Zentilin L; Tecchio G; Bianchi V; Paglialunga S; Levis AG
Mutat Res; 1985 Jun; 156(3):219-28. PubMed ID: 3889637
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic and clastogenic effects of soluble chromium compounds on mammalian cell cultures.
Levis AG; Majone F
Br J Cancer; 1979 Oct; 40(4):523-33. PubMed ID: 497104
[TBL] [Abstract][Full Text] [Related]
20. Role of solubilized chromium in the induction of morphological transformation of Syrian hamster embryo (SHE) cells by particulate chromium(VI) compounds.
Elias Z; Poirot O; Baruthio F; Danière MC
Carcinogenesis; 1991 Oct; 12(10):1811-6. PubMed ID: 1934262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
